Halozyme Therapeutics

Страна

USA

Краткое название

Halozyme Therapeutics

Штаб квартира

11388 Sorrento Valley Road

Члены правления

Gregory I. Frost , Ph.D. — President, Chief Executive Officer
Kurt A. Gustafson — Vice President, Chief Financial Officer
James P. Shaffer, MBA — Vice President, Chief Commercial Officer
H. Michael Shepard, Ph.D. — Vice President, Chief Scientific Officer
William J. Fallon — Vice President, Manufacturing & Operations
Don A. Kennard — Vice President, Regulatory Affairs & Quality Assurance
Michael J. LaBarre, Ph.D. — Vice President, Product Development
Jean I. Liu , M.S., J.D. — Vice President, General Counsel
Douglas B. Muchmore , M.D. — Vice President, Endocrinology Clinical Development
Joy Zhu , M.D., Ph.D — Vice President, Oncology Clinical Development

Разделы медицины

Эндокринология

Стадия проекта

Производство

Заболевания

Сахарный диабет

Тикер

HALO

Текущие владельцы

Robert L. Engler , M.D.
Kathryn E. Falberg
Gregory I. Frost , Ph.D.
Kenneth J. Kelley , Chairman of the Board of Directors
Randal J. Kirk
Connie L. Matsui John S. Patton , Ph.D.

Объем фонда

2.5900

Технологии

Клеточные технологии, Моноклональные антитела, Приборы, Технологии, Фармацевтика, Химия